Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 7 (2010), Issue 1 (January)

1. Conjunctival in vivo confocal scanning laser microscopy in patients with Sjögren syndrome.
   Invest Ophthalmol Vis Sci, 51(1): 144-50. [Abstract] [Full-text]
2. A case of sclerosing mesenteritis with rheumatoid arthritis.
   South Med J, 103(1): 96-7. [Abstract] [Full-text]
3. Dynamics of body composition and bone in patients with juvenile idiopathic arthritis treated with growth hormone.
   J Clin Endocrinol Metab, 95(1): 178-85. [Abstract] [Full-text]
4. Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome.
   Invest Ophthalmol Vis Sci, 51(2): 643-50. [Abstract] [Full-text]
5. Acute lymphoblastic leukemia masquerading as juvenile rheumatoid arthritis: diagnostic pitfall and association with survival.
   Ann Hematol, 89(3): 249-54. [Abstract] [Full-text]
6. Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study.
   Hypertension, 55(2): 333-8. [Abstract] [Full-text]
7. Decrease of blood dendritic cells and increase of tissue-infiltrating dendritic cells are involved in the induction of Sjögren's syndrome but not in the maintenance.
   Clin Exp Immunol, 159(3): 315-26. [Abstract] [Full-text]
8. Flk-1+ mesenchymal stem cells aggravate collagen-induced arthritis by up-regulating interleukin-6.
   Clin Exp Immunol, 159(3): 292-302. [Abstract] [Full-text]
9. The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease.
   Clin Exp Immunol, 159(3): 256-67. [Abstract] [Full-text]
10. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.
    Ann Rheum Dis, 69(2): 325-31. [Abstract] [Full-text]
11. Postpartum onset of rheumatoid arthritis and other chronic arthritides: results from a patient register linked to a medical birth registry.
    Ann Rheum Dis, 69(2): 332-6. [Abstract] [Full-text]
12. Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study.
    Ann Rheum Dis, 69(2): 345-51. [Abstract] [Full-text]
13. Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis.
    Ann Rheum Dis, 69(2): 409-12. [Abstract] [Full-text]
14. Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial.
    Ann Rheum Dis, 69(2): 413-6. [Abstract] [Full-text]
15. Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
    Ann Rheum Dis, 69(2): 387-93. [Abstract] [Full-text]
16. Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry.
    Ann Rheum Dis, 69(2): 380-6. [Abstract] [Full-text]
17. A diagnostic algorithm for persistence of very early inflammatory arthritis: the utility of power Doppler ultrasound when added to conventional assessment tools.
    Ann Rheum Dis, 69(2): 417-9. [Abstract] [Full-text]
18. Efficacy and safety of pamapimod in patients with active rheumatoid arthritis receiving stable methotrexate therapy.
    Ann Rheum Dis, 69(2): 364-7. [Abstract] [Full-text]
19. Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level.
    Ann Rheum Dis, 69(2): 450-7. [Abstract] [Full-text]
20. Association study of TRAF1-C5 polymorphisms with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese.
    Ann Rheum Dis, 69(2): 368-73. [Abstract] [Full-text]
21. National cohort study of reproductive risk factors for rheumatoid arthritis in Denmark: a role for hyperemesis, gestational hypertension and pre-eclampsia?
    Ann Rheum Dis, 69(2): 358-63. [Abstract] [Full-text]
22. Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review.
    Ann Rheum Dis, 69(2): 337-44. [Abstract] [Full-text]
23. Women with rheumatoid arthritis negative for anti-cyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody-positive women autoantibody levels are not influenced by pregnancy.
    Ann Rheum Dis, 69(2): 420-3. [Abstract] [Full-text]
24. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production.
    Science, 327(5965): 580-3. [Abstract] [Full-text]

© 2004-2012 Rheumatoid Arthritis Research Today. All Rights Reserved.